YOU ARE HERE: LAT HomeCollections

Classic cases of Broadway recycling

Revivals are more common than ever in New York, but is the trend driven by fear-based economics or merely a desire to put a fresh spin on popular productions?

October 13, 2012|By Steven Zeitchik, Los Angeles Times
  • Samuel Roukin, left, and Douglas Hodge in "Cyrano de Bergerac" at the Roundabout Theatre Company.
Samuel Roukin, left, and Douglas Hodge in "Cyrano de Bergerac"… (Joan Marcus )

NEW YORK — With a running time of three hours and a barrage of alcohol-fueled emotional cruelty, "Who's Afraid of Virginia Woolf?" would seem like an anomaly on today's frilly Broadway.

Or not.

Broadway this season has gone, well, a little classics-crazy. A version of Edward Albee's "Woolf' imported from Chicago's Steppenwolf Theatre is just one of five intense, iconic works playing this fall. The crop also includes Edmond Rostand's late-19th century touchstone "Cyrano de Bergerac," David Mamet's examination of modern male machismo "Glengarry Glen Ross," Henrik Ibsen's social treatise "An Enemy of the People" and Ruth and August Goetz's "The Heiress," derived from Henry James' novelistic staple "Washington Square."

But as the New York theater world embraces these seminal plays, is it a sign that producers think audiences crave serious plays or the latest evidence that the producers are running scared?

"There's a glass-half-full and a glass-half-empty way of seeing all this," said Lynne Meadow, the longtime artistic director of the not-for-profit Manhattan Theatre Club, staging "An Enemy of the People."


"The half-empty way is that it's a business and people need to make money, which you do with known work and bankable stars," Meadow said. "The half-full way is that this is vital work that's being reinvented with new actors." (Certainly the shows don't skimp on the recognizable stars — "The Heiress" features Hollywood actress-of-the-moment Jessica Chastain, while one of the most anticipated performances of the season is Al Pacino's in "Glengarry.")

Revivals of classics are nearly as old as Broadway itself, especially when it comes to musicals. But in recent years they have, as a rule, increased even among straight plays. In 2002, for instance, there were five time-tested classics revived the entire year, never mind in a few months. (More revivals of classics are coming this winter and spring, including a version of Tennessee Williams' "Cat on a Hot Tin Roof" with Scarlett Johansson.)

The cycles are also shortening. In 2000, Gore Vidal's "The Best Man" was revived for the first time in 40 years. It took barely a decade for the play to come back again.

"Virginia Woolf" and "Glengarry" were gone for even less time — they were staged on Broadway (and nominated by the Tonys for best revival of a play) just seven years ago.

Why this is happening — and whether it's a good thing — is a subject of a theater-world back-and-forth worthy of Albee's George and Martha.

Some involved say the decision to mount these shows reflects a deep cultural appetite.

"I think there's a real interest right now in embracing aspects of our past," said Paula Wagner, the veteran Hollywood producer who is producing "The Heiress." "The film world is making 'The Great Gatsby' and 'Anna Karenina,' and now you're seeing all these classics on Broadway. There are windows of time when we do that as a society, and we're in one of them now."

Others see less complicated reasons.

"I think it's economics, pure and simple," said Tracy Letts, the actor and Pulitzer Prize-winning playwright who is making his Broadway debut as an actor in "Woolf." "I mean, Al Pacino in 'Glengarry Glen Ross,' what the hell else do you need for a hit?"

There are clear financial advantages to reviving dramas. They're usually cheaper than musicals, since they don't tend to require elaborate staging, choreographers, composers or large casts. And they come with a certain built-in marketing advantage, since even casual theatergoers will know their name and bona fides.


"These dramatic revivals, even if they're very serious works, really are the lowest risk," said Todd Haimes, artistic director at the not-for-profit Roundabout Theatre Company, which is staging "Cyrano."

Of course, even if people know these plays, there's the pesky issue of persuading them to buy tickets. No matter how many stars these shows contain, American audiences haven't shown a consistent desire to spend a night with the human complications often dealt with in dramatic classics.

The Andrew Garfield-Philip Seymour Hoffman revival of "Death of a Salesman," for instance, may have been one of Broadway's biggest hits over the past few years, but other name-driven productions, such as the Kim Cattrall-toplined revival of Noel Coward's "Private Lives" and the Bill Pullman-Julia Stiles edition of Mamet's "Oleanna," to name two examples, were disappointments.

Meanwhile, some fear that all these familiar works are crowding out new voices.

Los Angeles Times Articles